Evidence map›Paper›PMID 41550407›Full record

ArticleClinical case reports2026

Integrating Artificial Intelligence Into Exposure Therapy: A One Year Follow-Up Case Report of Emetophobia With Comorbid Panic Disorder.

U Selen Kilic

Abstract read
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

U Selen KilicPrivate Practice Istanbul Türkiye.ORCID https://orcid.org/0009-0006-7968-6616

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emetophobia is a specific phobia characterized by an intense fear of vomiting, often accompanied by panic attacks, hypervigilance to bodily sensations, and avoidance behaviors. This case study describes the Cognitive Behavioral Therapy (CBT)-based treatment of a 24-year old woman with Emetophobia and comorbid panic disorder. Her symptoms caused significant impairment, leading her to avoid social settings, public spaces, and situations linked to vomiting (e.g., dining out, public transport, certain media content). Treatment followed a structured CBT protocol for specific phobias, including psychoeducation, cognitive restructuring, exposure therapy, response prevention and attention-shifting techniques. A novel feature of the intervention was the inclusion of brief, spoken interactions in English with a speech-based artificial intelligence tool ChatGPT. As English was not the client's first language, these interactions required increased cognitive effort, serving as a structured external distraction that facilitated habituation by helping her remain in anxiety-provoking situations without relying on safety behaviors. Treatment progress was tracked using validated self-report measures including the Specific Phobia of Vomiting Inventory, the Emetophobia Questionnaire-13 and Panic Disorder Severity Scale. Substantial symptom reduction was observed across domains, with improvements maintained at one-year follow-up. By the end of therapy, the client no longer depended on safety behaviors and demonstrated greater tolerance for bodily sensations and uncertainty. This case highlights the potential of CBT for treating Emetophobia and suggests that the integration of artificial intelligence, when applied with clear clinical rationale, may improve attentional flexibility and enhance treatment engagement.

Indexed as

artificial intelligenceChatGPTcognitive behavioral therapyemetophobiaexposure therapypanic disorder

Identifiers

PMID41550407
PMCPMC12809255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.